Parallel Advisors, LLC
Position in CERO — Cero Therapeutics Holdings, Inc.
CIK 1690010
SAN FRANCISCO, CA
Position in CERO
as of Sep 30, 2025
· filed Nov 13, 2025
Position Value
$615,890
-$1,502,710 QoQ
Shares Held
148,500
-45.0% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1
of 11 holders
Holding Since
Mar 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CERO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $359,916,636 across 168 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CORT |
Corcept Therapeutics Inc
|
3,962,177 | $344,511,290 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,389 | $2,676,877 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
|
86,557 | $2,668,552 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,063 | $662,823 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
1,699 | $631,467 | |
| 6 | ARGX |
Argenx SE
|
640 | $593,772 | |
| 7 | INCY |
Incyte Corp
|
4,961 | $562,378 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
13,833 | $539,625 |
All Filings in CERO
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-09-30 CEROW | — | 27,500 | Shares | Sole | 2025-11-13 | |
| 2025-09-30 | $615,890 | 121,000 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 CEROW | — | 50,000 | Shares | Sole | 2025-07-08 | |
| 2025-06-30 | $2,118,600 | 220,000 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 CEROW | — | 50,000 | Shares | Sole | 2025-04-08 | |
| 2025-03-31 | $160,600 | 220,000 | Shares | Sole | 2025-04-08 | |
| No filing history on record for this holder in this stock. | ||||||